Biomarkers Screening Between Preoperative and Postoperative Patients in Pancreatic Cancer.

Pei Li,Juan Yang,Qing-Yong Ma,Zheng Wu,Chen Huang,Xu-Qi Li,Zheng Wang
DOI: https://doi.org/10.7314/apjcp.2013.14.7.4161
2013-01-01
Asian Pacific Journal of Cancer Prevention
Abstract:OBJECTIVE:To investigate discriminating protein patterns and potential biomarkers in serum samples between pre/postoperative pancreatic cancer patients and healthy controls.METHODS:23 serum samples from PC patients (12 preoperative and 11 postoperative) and 76 from healthy controls were analyzed using matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) technique combined with magnetic beads-based weak cation-exchange chromatography (MB-WCX). ClinProTools software selected several markers that made a distinction between pancreatic cancer patients and healthy controls.RESULTS:49 m/z distinctive peaks were found among the three groups, of which 33 significant peaks with a P < 0.001 were detected. Two proteins could distinguish the preoperative pancreatic cancer patients from the healthy controls. About 15 proteins may be potential biomarkers in assessment of pancreatic cancer resection.CONCLUSION:MB-MALDI-TOF-MS method could generate serum peptidome profiles of pancreatic cancer and provide a new approach to identify potential biomarkers for diagnosis and prognosis of this malignancy.
What problem does this paper attempt to address?